Showing 441 - 460 results of 102,292 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( 5 ((nm decrease) OR (we decrease)) ))', query time: 1.15s Refine Results
  1. 441
  2. 442
  3. 443

    Supplementary Material for: Decrease of Hyperintense Vessels on Fluid-Attenuated Inversion Recovery Predicts Good Outcome in t-PA Patients by Sakuta K. (4147642)

    Published 2016
    “…<b><i>Results:</i></b> A total of 118 consecutive patients were enrolled (73 men; mean age 76 ± 9.7; median initial National Institutes of Health Stroke Scale (NIHSS) 13; median initial HV score 5), of whom 52 (44%) had DHV. …”
  4. 444

    The decrease in lactate induced by pyruvate is blocked by inhibition of MAS and of the TCA cycle in HKI/HKII double KD cells. by Scott John (228011)

    Published 2023
    “…Following the decrease in lactate evoked by pyruvate, addition of AOA reversed this effect, causing a rapid increase in lactate. …”
  5. 445
  6. 446
  7. 447
  8. 448
  9. 449

    Differentially regulated genes in cells with increased or decreased expression of miR-106a-5p. by Feng Zhi (294362)

    Published 2013
    “…(C) A Venn diagram of the overlap of altered genes with increased or decreased miR-106a-5p expression. …”
  10. 450

    NaSal increased the excitability of 5-HTergic neurons, but decreased that of GABAergic neurons in the DRN of the ChR2 transgenic mouse. by Yan Jin (143500)

    Published 2015
    “…(D) Sample traces (left panel) and group data (right panel, paired Student’s <i>t</i>-test) showing that NaSal suppressed the firing of GABAergic neurons evoked by laser light (1 s, 5.5 mW, 473 nm). (E) Sample recordings from a GABAergic neuron showing that NaSal decreased voltage responses to a series of hyperpolarizing currents (-10 to -60 pA, -10 pA/step, duration: 500 ms). …”
  11. 451
  12. 452
  13. 453
  14. 454
  15. 455
  16. 456
  17. 457
  18. 458
  19. 459
  20. 460

    Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”